FDA has issued a new document – “Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile Guidance for Industry and Food and Drug Administration Staff.”
The
introduction to the document reads:
“This
guidance document updates and clarifies the information regarding sterilization
processes that we recommend sponsors include in 510(k)s for devices labeled as
sterile. This guidance document also provides details about the pyrogenicity
information that we recommend sponsors include in a 510(k) submission. For the
current edition of the FDA-recognized standards referenced in this document, see
the FDA Recognized Consensus Standards Database Web site at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm.
FDA's
guidance documents, including this guidance, do not establish legally
enforceable responsibilities. Instead, guidances describe the Agency's current
thinking on a topic and should be viewed only as recommendations, unless
specific regulatory or statutory requirements are cited. The use of the word
should in Agency guidances means that something is suggested or recommended,
but not required.”
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources